MDxHealth, EHC Innovation Collaborate
News Sep 29, 2016
MDxHealth SA has announced that it has signed a distribution agreement with The European Health Centre Innovation (EHC Innovation) to offer its SelectMDx(TM) for Prostate Cancer and ConfirmMDx® for Prostate Cancer tests to their urology customers throughout Poland.
Under the terms of the agreement, EHC Innovation will be one of two exclusive distributors of SelectMDx in Poland and the only exclusive distributor of ConfirmMDx. Samples will be sent to MDxHealth's clinical diagnostic laboratory in Nijmegen, The Netherlands for analysis. EHC Innovation will reimburse MDxHealth for all testing services.
"We are delighted to announce our collaboration with The European Health Centre Innovation which, as part of European Health Center Otwock Hospital, is the most technologically advanced multispecialty diagnostic centre in Poland. We believe that SelectMDx and ConfirmMDx perfectly complement EHC Innovation's existing portfolio of advanced diagnostic tools," commented Dr. Jan Groen, CEO of MDxHealth.
"With a strong reputation throughout the region and focus on improving patient care and outcomes, EHC Innovation is an ideal partner to help us raise awareness and expand access to SelectMDx and ConfirmMDx within the urology community."
Breakthrough Leads to New Research Into Cancer Treatment for ChildrenNews
The new form of treatment is based on the protein molecule named CD40, which destroys cancerous tumours without harming healthy cell tissue.READ MORE
Generating T Cells With a More Powerful Anti-cancer EffectNews
Studies of two T cell types that are equally activated by alpha-fetoprotein, a well-established antigen made by liver cancer, show that while one starts off with a bang, the other endures as the more powerful tumor fighter.READ MORE
Cancer Cells’ Energy Source Blocked by Natural CompoundNews
Researchers have not only untangled an unusual wiring system that cancer cells use for carbohydrate metabolism, but also identified a natural compound that appears to selectively shut down this system in laboratory studies.READ MORE